State Street
NVNO

State Street’s enVVeno Medical NVNO Stock Holding History

State Street’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,166
Closed -$13.1K – 4318
2025
Q4 		$13.1K Hold
1,166
– – ﹤0.01% 4262
2025
Q3 		$37K Hold
1,166
– – ﹤0.01% 4188
2025
Q2 		$163K Hold
1,166
– – ﹤0.01% 3886
2025
Q1 		$107K Hold
1,166
– – ﹤0.01% 3961
2024
Q4 		$123K Buy
1,166
+409
+54% +$45.7K ﹤0.01% 3950
2024
Q3 		$89K Hold
757
– – ﹤0.01% 4000
2024
Q2 		$139K Buy
757
+54
+8% +$9.43K ﹤0.01% 3919
2024
Q1 		$134K Sell
703
-57
-8% -$10.2K ﹤0.01% 3968
2023
Q4 		$137K Hold
760
– – ﹤0.01% 3983
2023
Q3 		$143K Buy
760
+146
+24% +$24.4K ﹤0.01% 4020
2023
Q2 		$66.2K Hold
614
– – ﹤0.01% 4338
2023
Q1 		$102K Hold
614
– – ﹤0.01% 4321
2022
Q4 		$110K Hold
614
– – ﹤0.01% 4346
2022
Q3 		$135K Hold
614
– – ﹤0.01% 4314
2022
Q2 		$81K Hold
614
– – ﹤0.01% 4601
2022
Q1 		$137K Buy
614
+23
+4% +$4.46K ﹤0.01% 4528
2021
Q4 		$136K Buy
591
+80
+16% +$22.5K ﹤0.01% 4497
2021
Q3 		$186K Sell
511
-66
-11% -$17.1K ﹤0.01% 4379
2021
Q2 		$139K Buy
+577
New +$124K ﹤0.01% 4300

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street's NVNO Position: Q1 2026 in Review

State Street sold out of enVVeno Medical (NVNO) in Q1 2026, closing a stake of 1,166 shares — an estimated $13.1K sold.

State Street first reported a position in NVNO in Q2 2021 and held it in 19 quarters. The position peaked at $186K in Q3 2021. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • State Street reported no remaining enVVeno Medical position as of Q1 2026 after selling out during the quarter.
  • State Street sold 1,166 enVVeno Medical shares in Q1 2026, an estimated $13.1K.
  • State Street first reported a position in enVVeno Medical in Q2 2021 and held it in 19 quarters.
  • State Street's enVVeno Medical position peaked at $186K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.